- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04629989
Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19
March 8, 2021 updated by: Poncin, Cliniques universitaires Saint-Luc- Université Catholique de Louvain
The Effects of Two Systems Above Low-flow Nasal Cannula on Arterial Oxygen Tension in Patients With COVID-19 : Surgical Face Mask Versus Double-trunk Mask
This study will compare the impact of two systems above low-flow nasal cannula on the arterial oxygen tension in patients with COVID-19.
The two systems are the Surgical Mask (SM) and the Double-Trunk Mask (DTM).
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Hospitalized patients with COVID-19 typically present with hypoxemia.
In some patients, hypoxemia can be corrected with low flow nasal cannula.
When placed above nasal cannula, some systems have demonstrated their interest in improving the performance of patient's oxygen delivery.
For example, two recent studies have shown that adding a Double-Trunk Mask (DTM) or Surgical Mask (SM) above nasal cannula has the potential to improve the PaO2 despite no change in oxygen output (Duprez et al., J Clin Monit Comput 2020; Montiel et al., Ann Intensive Care 2020).
However, there is no study comparing the relative effectiveness of these 2 systems.
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brussels, Belgium, 1200
- Cliniques Universitaires Saint-luc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- COVID-19 positive
- SpO2 between 92 and 96% with low-flow oxygen therapy
- Oxygen output at baseline between 3 and 7 L/min.
Exclusion Criteria:
- Pulmonary disease with hypercapnia
- Confusion
- Contra-indications to arterial blood gas sampling (peripheral arteriopathy, bleeding disorder)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Low-flow nasal cannula
The standard oxygen delivery system (low-flow nasal cannula) is worn by the patient, without the DTM or the SM
|
The standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.
|
|
Experimental: Double-Trunk Mask
The Double-Trunk Mask is placed above the standard oxygen delivery system (low-flow nasal cannula).
|
The Double-Trunk Mask above the standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.
|
|
Experimental: Surgical Mask
The Surgical Mask is placed above the standard oxygen delivery system (low-flow nasal cannula).
|
The Surgical Mask above the standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in PaO2
Time Frame: At baseline and 30 minutes after wearing the randomized oxygen delivery system
|
Oxygen tension (PaO2) in mmHg will be analyzed from a sample taken from the arterial system
|
At baseline and 30 minutes after wearing the randomized oxygen delivery system
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in PaCO2
Time Frame: At baseline and 30 minutes after wearing the randomized oxygen delivery system
|
Carbon dioxide tension (PaCO2) in mmHg will be analyzed from a sample taken from the arterial system.
|
At baseline and 30 minutes after wearing the randomized oxygen delivery system
|
|
Change in pH
Time Frame: At baseline and 30 minutes after wearing the randomized oxygen delivery system
|
Potential of Hydrogen (pH) will be analyzed from a sample taken from the arterial system.
|
At baseline and 30 minutes after wearing the randomized oxygen delivery system
|
|
Change in respiratory rate
Time Frame: At baseline, 30 minutes and 60 minutes after wearing the randomized oxygen delivery system
|
Respiratory rate is measured during one minute by visual inspection.
|
At baseline, 30 minutes and 60 minutes after wearing the randomized oxygen delivery system
|
|
Change in dyspnea
Time Frame: At baseline and 60 minutes after wearing the randomized oxygen delivery system
|
Dyspnea is rated with a visual analogic scale (0 to 100mm).
|
At baseline and 60 minutes after wearing the randomized oxygen delivery system
|
|
Change in O2 output
Time Frame: At 30 minutes and 60 minutes after wearing the randomized oxygen delivery system
|
The O2 output will be adjusted to recover the baseline SpO2 reading.
The O2 output will be read from the position of the ball inside the flowmeter.
|
At 30 minutes and 60 minutes after wearing the randomized oxygen delivery system
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 13, 2020
Primary Completion (Actual)
March 5, 2021
Study Completion (Actual)
March 5, 2021
Study Registration Dates
First Submitted
November 13, 2020
First Submitted That Met QC Criteria
November 13, 2020
First Posted (Actual)
November 16, 2020
Study Record Updates
Last Update Posted (Actual)
March 9, 2021
Last Update Submitted That Met QC Criteria
March 8, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DTM-003
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Standard Oxygen Delivery System
-
University of Missouri-ColumbiaTyco Healthcare GroupCompleted
-
University of UtahCompletedPatient Monitoring | Oxygen Delivery | Patient ComfortUnited States
-
Tufts Medical CenterFisher and Paykel HealthcareCompletedAcute Respiratory Failure | Treatment With Noninvasive Positive Pressure VentilationUnited States
-
Unity Health TorontoUnknown
-
The University of Texas Health Science Center,...TerminatedLung Diseases, ObstructiveUnited States
-
Western Galilee Hospital-NahariyaCompletedAcute AppendicitisIsrael
-
University of UtahActive, not recruiting
-
Virginia Polytechnic Institute and State UniversityCarilion ClinicCompletedRespiratory Failure With HypoxiaUnited States
-
Children's Hospitals and Clinics of MinnesotaUnknownHypoxia | BronchiolitisUnited States
-
University of CincinnatiUnited States Air ForceCompletedHypoxemia | Hypobaric HypoxemiaUnited States